AdiStem Announces PhotoActivated PRP Getting Superb Results on Joint Pain
|| Print ||
|Monday, 08 October 2012 01:00 (UTC + 2)|
Melbourne, Australia, October 8, 2012 / B3C newswire / – AdiStem Ltd., a provider of PhotoActivation Technology and medical solutions that assist in orthopedic, cosmetic, neurologic, pulmonary, metabolic and plastic/reconstructive surgery procedures, announces today that photoactivated PRP (Platelet Rich Plasma) prior to injection reduces pain and accelerates healing.
PRP injections have been emerging as a treatment for joint pain and osteoarthritis for some years. But many orthopaedic doctors have now found that photoactivating PRP prior to injection reduces pain even further – and accelerates healing.
This was demonstrated in a recent study of 102 patients in Australia suffering severe knee, hip, shoulder, elbow and joint pain in which their PPR was photoactivated prior to injection into the affected area. An independent doctor audit subsequently showed that 80% of patients aged 40-70 in this Study experienced “reduced pain” and were “satisfied” with the result. Heading the Study was Dr. Peter Lewis, Sports Medicine Physician, specializing in Martial Arts and Australian Rules Football. He later observed: “I’m now doing at least 50 Photoactivated PRP injections every week. I’ve been getting dramatic results and am enthusiastic about it. My practice has grown significantly as a result – and I have had to appoint more doctors.”
In this new PRP procedure the doctor draws blood, places it in a centrifuge to separate the PRP from the red blood cells and then photoactivates the PRP for 10 minutes before injection back into the patient’s joint pain or injury. In this way photoactivation has been found to stimulate cartilage and tissue repair and to reduce pain and inflammation to the extent of either delaying invasive surgery or even making it unnecessary. A key component in the PRP photoactivation procedure is Adi-Light (from Adistem Ltd) which uses low intensity light at specific frequencies to increase the secretion of various anti-inflammatory and healing agents from peripheral blood cells and platelets into the PRP.
But according to Dr. Vasilis Paspaliaris, the medical scientist who developed the Adi-Light unit for Adistem Ltd., photoactivation actually does more than that: “Photactivation seems to increase the secretion of tiny vesicles (exosomes) from peripheral blood white blood cells, stem cells and platelets”. Adistem were initially made aware of this through its ongoing research into cell photoactivation which has in part been carried out on their behalf by Australia’s National Science Agency (CSIRO).
An early user of photactivated PRP has been Dr. Joseph Purita in Florida, USA, Head of the Institute of Regenerative & Molecular Orthopaedics and a Fellow of the American Academy of Orthopedic Surgeons. He comments:
“I am an orthopedic surgeon who has been in private practice for 31 years. A number of years ago I became convinced that regenerative medicine would be the future of orthopedics and sports medicine. The first Quantum leap in my regenerative medicine practice was the use of PRP injections. My next Quantum leap was the discovery of Adi-Light. I started using the Light on the day I and a number of other doctors were trained by Adistem – and I have never looked back. I find this Light to be an invaluable resource for achieving excellent results. Adi-Light dramatically reduces inflammation, increases the production of natural pain killers and seems to make the PRP or stem cells better at doing their job. I have used Adi-Light on numerous professional athletes with superb results.”
Adistem Ltd. has been supplying photoactivation units since 2008. An improved, lower cost model, Adi-Light 2, has recently been introduced (October, 2012).